Allergen Provocations- HCA Children's Hospital

November 2, 2023 updated by: Josefine Gradman

Allergen Provocations at Hans Christian Andersen Children's Hospital

A prospective study of all allergen provocations performed in children at the Hans Christian Andersen Children's Hospital.

Study Overview

Status

Recruiting

Conditions

Detailed Description

The purpose of the study is to investigate the impact of co-morbidities, history, and allergen tests on the outcome of allergen provocation tests.

Subjects are children aged 0-18 years old investigated for allergy to foods or antibiotics. Data entered in the database are demographics, co-morbidities, symptoms, SPT, specific IgE and details of the allergen provocations.

Study Type

Observational

Enrollment (Estimated)

8000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Odense C
      • Odense, Odense C, Denmark, 5000
        • Recruiting
        • Hans Christian Andersen Children's Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 16 years (Child, Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Children referred to the department of pediatrics for investigation of allergy to foods or antibiotics

Description

Inclusion Criteria:

clinical suspicion of allergy to foods or antibiotics informed concent -

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Antibiotics
Children aged 0-18 years investigated for allergy to antibiotics
Titrated provocation with allergen
Milk
Children aged 0-18 years investigated for allergy to milk
Titrated provocation with allergen
Egg
Children aged 0-18 years investigated for allergy to egg
Titrated provocation with allergen
Peanut
Children aged 0-18 years investigated for allergy to peanut
Titrated provocation with allergen
Hazelnut
Children aged 0-18 years investigated for allergy to hazelnut
Titrated provocation with allergen
Sesame
Children aged 0-18 years investigated for allergy to sesame
Titrated provocation with allergen
Wheat
Children aged 0-18 years investigated for allergy to wheat
Titrated provocation with allergen
walnut
Children aged 0-18 years investigated for allergy to walnut
Titrated provocation with allergen
cashew
Children aged 0-18 years investigated for allergy to cashew
Titrated provocation with allergen
Pistachio
Children aged 0-18 years investigated for allergy to pistachio
Titrated provocation with allergen
Almond
Children aged 0-18 years investigated for allergy to almond
Titrated provocation with allergen
Soy
Children aged 0-18 years investigated for allergy to soy
Titrated provocation with allergen
Fish
Children aged 0-18 years investigated for allergy to fish
Titrated provocation with allergen
Shellfish
Children aged 0-18 years investigated for allergy to shellfish
Titrated provocation with allergen
Poppy seed
Children aged 0-18 years investigated for allergy to poppy seed
Titrated provocation with allergen

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The association of allergy tests with the result of allergen provocation
Time Frame: 5 years
The value of specific IgE and SPT to predict the outcome of a allergen provocation
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2018

Primary Completion (Estimated)

October 1, 2038

Study Completion (Estimated)

October 1, 2039

Study Registration Dates

First Submitted

March 31, 2020

First Submitted That Met QC Criteria

March 31, 2020

First Posted (Actual)

April 2, 2020

Study Record Updates

Last Update Posted (Estimated)

November 3, 2023

Last Update Submitted That Met QC Criteria

November 2, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • HCA-AP

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Allergy in Children

Clinical Trials on Oral provocation test

3
Subscribe